Cargando…

Urinary retention after use of decitabine in acute myeloid leukemia: case report

Detalles Bibliográficos
Autores principales:	Nunes, Viviane Regina Hernandez, e Pimentel, Isabella Silva, Kerbauy, Mariana Nassif, Feres, Carolina Cristina Pellegrino, Nascimento, Jade Zezzi Martins do, Ribeiro, Andreza Alice Feitosa, Santos, Amanda Inacio Dias dos, Wroclawski, Marcelo Langer, Teixeira, Larissa Lane Cardoso, Hamerschlak, Nelson
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Hematologia e Hemoterapia 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938488/ https://www.ncbi.nlm.nih.gov/pubmed/34257059 http://dx.doi.org/10.1016/j.htct.2021.04.008

Ejemplares similares

Progressive multifocal leukoencephalopathy in a patient with relapsed chronic lymphocytic leukemia treated with Ibrutinib
por: Teixeira, Larissa Lane Cardoso, et al.
Publicado: (2022)

Molecular profile of patients with myelofibrosis: a 10-year experience
por: Dias, Lara Faria Souza, et al.
Publicado: (2022)

Need for hemodialysis in patients undergoing hematopoietic stem cell transplantation: risk factors and survival in a retrospective cohort
por: Chapchap, Eduardo Cerello, et al.
Publicado: (2023)

Diffuse large B-cell lymphoma of the central nervous system presenting as “lymphomatosis cerebri” and dementia in elderly man: Case report and review of the literature
por: Kerbauy, Mariana Nassif, et al.
Publicado: (2019)

Total marrow irradiation in hematopoietic stem cell transplantation for hematologic malignancies
por: Kerbauy, Mariana Nassif, et al.
Publicado: (2023)

PB2359: SYNCHRONOUS SOLID TUMORS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: EXPERIENCE IN A PUBLIC HEALTHY SYSTEM IN BRAZIL.
por: Teixeira, Larissa, et al.
Publicado: (2023)

P1184: INTERIM DELTASUVMAX CAN IDENTIFY PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA WITH A HIGH RISK OF PRIMARY REFRACTORY DISEASE CANDIDATES FOR EARLY CART COLLECTION
por: Feres, Carolina, et al.
Publicado: (2023)

Di-O-lauroyl-decitabine-lipid nanocapsules: toward extending decitabine activity
por: Briot, Thomas, et al.
Publicado: (2019)

New US Preventive Service Task Force recommendations for prostate cancer screening: a needed update, but not enough
por: Wroclawski, Marcelo Langer
Publicado: (2017)

Decitabine in the treatment of myelodysplastic syndromes
por: Saba, Hussain I
Publicado: (2007)

Decitabine/Cedazuridine: First Approval
por: Dhillon, Sohita
Publicado: (2021)

DESFECHOS DE PACIENTES PORTADORES DE DOENÇAS LINFOPROLIFERATIVAS INFECTADOS COM COVID-19
por: Marques, CP, et al.
Publicado: (2021)

Survival, toxicity and length of stay after haploidentical or cord blood transplantation in a Latin American center: a cross-sectional, comparative study
por: Esteves, I, et al.
Publicado: (2017)

Mechanisms of Resistance to Decitabine in the Myelodysplastic Syndrome
por: Qin, Taichun, et al.
Publicado: (2011)

Correction to: Decitabine/Cedazuridine: First Approval
por: Dhillon, Sohita
Publicado: (2020)

Decitabine Promotes Modulation in Phenotype and Function of Monocytes and Macrophages That Drive Immune Response Regulation
por: Zambuzi, Fabiana Albani, et al.
Publicado: (2021)

Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis
por: Kwag, Daehun, et al.
Publicado: (2022)

Do we have enough evidences that make you safe to treat a man with hypogonadism one year after a radical prostatectomy for prostate cancer? | Opinion: Not Yet
por: Wroclawski, Marcelo Langer, et al.
Publicado: (2018)

Mixed-phenotype acute leukemia treated with decitabine
por: Lee, Ji-Young, et al.
Publicado: (2016)

Epigenetic synergy between decitabine and platinum derivatives
por: Qin, Taichun, et al.
Publicado: (2015)

Spotlight on decitabine for myelodysplastic syndromes in Chinese patients
por: Jing, Yu, et al.
Publicado: (2015)

Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy
por: Agasthi, Pradyumna, et al.
Publicado: (2018)

Expression of decitabine-targeted oncogenes in meningiomas in vivo
por: Canisius, Julian, et al.
Publicado: (2022)

Acquired resistance to decitabine and cross-resistance to gemcitabine during the long-term treatment of human HCT116 colorectal cancer cells with decitabine
por: HOSOKAWA, MIKA, et al.
Publicado: (2015)

Guidelines of the Brazilian society of bone Marrow transplantation on hematopoietic stem cell transplantation as a treatment for the autoimmune diseases systemic sclerosis and multiple sclerosis
por: Rodrigues, Maria Carolina de Oliveira, et al.
Publicado: (2013)

Decitabine Induced Transient Cardiomyopathy: A Case Report
por: De, Chitradeep, et al.
Publicado: (2012)

An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes
por: Garcia, Jacqueline S, et al.
Publicado: (2010)

Decitabine reactivated pathways in platinum resistant ovarian cancer
por: Fang, Fang, et al.
Publicado: (2014)

Decitabine in the treatment of acute myeloid leukemia in elderly patients
por: Malik, Priya, et al.
Publicado: (2014)

Direct but No Transgenerational Effects of Decitabine and Vorinostat on Male Fertility
por: Kläver, Ruth, et al.
Publicado: (2015)

Effects of decitabine on megakaryocyte maturation in patients with myelodysplastic syndromes
por: DING, KAI, et al.
Publicado: (2016)

Decitabine: a historical review of the development of an epigenetic drug
por: de Vos, Dick, et al.
Publicado: (2005)

Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
por: Goswami, Meghali, et al.
Publicado: (2022)

Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes
Publicado: (2022)

Selinexor in Combination with Decitabine Attenuates Ovarian Cancer in Mice
por: Stiff, Patrick J., et al.
Publicado: (2023)

Clinical Characteristics and Outcomes of COVID-19 in HSCT Recipients
por: Machado, Clarisse MARTINS, et al.
Publicado: (2020)

Bone marrow transplantation and acute myeloid leukemia: Brazilian guidelines
por: Silla, Lucia Mariano da Rocha, et al.
Publicado: (2013)

A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America
por: José, Fabio Freire, et al.
Publicado: (2017)

Establishment and molecular characterization of decitabine‐resistant K562 cells
por: Wen, Xiang‐Mei, et al.
Publicado: (2019)

Novel prodrugs of decitabine with greater metabolic stability and less toxicity
por: Hattori, Naoko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jgud7i70o92m32hf9djq291ld5